Трудности регистрации медицинских изделий в ЕАЭС
March 26, 2024
November 09, 2020
Webinar: EAEU Regulatory Challenges and Opportunities
EXTEDO and Inpharmatis invite you to our joint complimentary webinar"Regulatory Challenges and Opportunities in the EAEU". |
||||||||||||||||||||||||||||||||||||||||||
In this webinar, we will discuss the regulations and requirements for electronic submissions in the Eurasian Economic Union (Russia, Belarus, Kazakhstan, Armenia and Kyrgyzstan) and show you, how EXTEDO and Inpharmatis can support you in getting your products on the EAEU market faster. | ||||||||||||||||||||||||||||||||||||||||||
REGISTER NOW | ||||||||||||||||||||||||||||||||||||||||||
Konstantin Koshechkin, the leading expert of the Russian Federation Health Authority will present experiences with EAEU submissions at regulatory agency level, expanding on recommended approaches and strategies for submissions. | ||||||||||||||||||||||||||||||||||||||||||
EAEU expert Polina Dombure from EXTEDO's partner Inpharmatis will talk about the challenges when submitting electronic submissions in the EAEU countries. She will give useful hints on what needs to be considered when creating and validating these submissions and which regulatory strategy would help you in this region. | ||||||||||||||||||||||||||||||||||||||||||
Maren Müller will demonstrate how EXTEDO's Word templates and the apps eCTDmanager and eSUBmanager could streamline your authoring and submission processes regarding the EAEU countries by offering compliant templates, automated processes and useful functionalities. | ||||||||||||||||||||||||||||||||||||||||||
Following the presentation, the speakers will answer your questions in the Q&A session. | ||||||||||||||||||||||||||||||||||||||||||
Agenda:
|
Challenges of Medical Devices Registration in the EAEU
March 26, 2024Новые поправки к Федеральному закону "Об обращении лекарственных средств" в России
March 13, 2024New Amendments in Federal Law “On Circulation of Medicines” in Russia
March 13, 2024В Грузии фармацевтические компании, не предоставившие сертификат GMP, столкнулись с новыми рисками
February 28, 2024In Georgia, Pharmaceutical Companies That Have Not Provided a GMP Certificate are Facing New Risks
February 28, 2024Получение GMP сертификата ЕАЭС обязательная процедура
February 21, 2024EAEU GMP Certificate is Mandatory
February 20, 2024Полина Домбуре, директор Inpharmatis, приняла участие в TOPRA Summit 2024
February 19, 2024Dr. Polina Dombure, Inpharmatis CEO, Participated in TOPRA Summit 2024
February 19, 2024